Carrozzino Danilo, Porcelli Piero
Department of Psychological, Health and Territorial Sciences, University "G.d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Psychiatric Research Unit, Psychiatric Centre North Zealand, Copenhagen University Hospital, Hillerød, Denmark.
Front Psychol. 2018 Apr 6;9:470. doi: 10.3389/fpsyg.2018.00470. eCollection 2018.
Alexithymia is a multifaceted personality construct that represents a deficit in the cognitive processing of emotions and is currently understood to be related to a variety of medical and psychiatric conditions. The present review aims to investigate the relationship of alexithymia with gastrointestinal (GI) disorders as functional gastrointestinal disorders (FGID, as irritable bowel syndrome (IBS) and functional dyspepsia) and inflammatory bowel disease (IBD) [ulcerative colitis (UC) and Crohn's disease (CD)] and liver diseases as chronic hepatitis C (CHC), cirrhosis, and liver transplantation. The articles were selected from the main electronic databases (PsycInfo, Medline, PubMed, Web of Science, Scopus, Cochrane, and ScienceDirect) using multiple combinations of relevant search terms (defined GI and liver diseases, articles in English, use of the Toronto scales [TAS] for alexithymia). The TAS was selected as inclusion criterion because it is the most widely used measure, thus allowing comparisons across studies. Forty-eight studies met the inclusion criteria, of which 38 focused on GI disorders (27 on FGID and 11 on IBD) and 10 on liver diseases. Most studies ( = 30, 62%) were cross-sectional. The prevalence of alexithymia was higher in FGID (two third or more) than IBD and liver diseases (from one third to 50% of patients, consistent with other chronic non-GI diseases) than general population (10-15%). In functional disorders, alexithymia may be viewed as a primary driver for higher visceral perception, symptom reporting, health care use, symptom persistence, and negative treatment outcomes. Also, it has been found associated with psychological distress and specific GI-related forms of anxiety in predicting symptom severity as well as post-treatment outcomes and is associated with several psychological factors increasing the burden of disease and impairing levels of quality of life. A number of critical issues (small sample sizes, patients referred to secondary and tertiary care centers, cross-sectional study design, use of one single scale for alexithymia) constitutes a limitation to the generalization of findings. Alexithymia showed to play different roles in gastroenterology according to the clinical characteristics and the psychological burden of the various disorders, with main relevance in increasing subjective symptom perception and affecting negatively post-treatment outcomes.
述情障碍是一种多方面的人格结构,表现为情绪认知加工方面的缺陷,目前被认为与多种医学和精神疾病有关。本综述旨在研究述情障碍与胃肠道(GI)疾病(如功能性胃肠疾病(FGID),如肠易激综合征(IBS)和功能性消化不良)、炎症性肠病(IBD)[溃疡性结肠炎(UC)和克罗恩病(CD)]以及肝脏疾病(如慢性丙型肝炎(CHC)、肝硬化和肝移植)之间的关系。文章从主要电子数据库(PsycInfo、Medline、PubMed、Web of Science、Scopus、Cochrane和ScienceDirect)中选取,使用了相关检索词的多种组合(定义GI和肝脏疾病、英文文章、使用多伦多述情障碍量表(TAS))。选择TAS作为纳入标准是因为它是使用最广泛的测量方法,从而便于跨研究进行比较。48项研究符合纳入标准,其中38项聚焦于GI疾病(27项关于FGID,11项关于IBD),10项关于肝脏疾病。大多数研究(n = 30,62%)为横断面研究。FGID中述情障碍的患病率(三分之二或更高)高于IBD和肝脏疾病(患者的三分之一至50%,与其他慢性非GI疾病一致),高于普通人群(10 - 15%)。在功能性疾病中,述情障碍可被视为更高内脏感知、症状报告、医疗保健使用、症状持续以及负面治疗结果的主要驱动因素。此外,在预测症状严重程度以及治疗后结果方面,已发现它与心理困扰和特定的GI相关焦虑形式有关,并且与增加疾病负担和损害生活质量水平的多种心理因素有关联。一些关键问题(样本量小、患者来自二级和三级护理中心、横断面研究设计、使用单一的述情障碍量表)限制了研究结果的推广。述情障碍根据各种疾病的临床特征和心理负担在胃肠病学中发挥不同作用,主要与增加主观症状感知和对治疗后结果产生负面影响有关。